04:25 AM EST, 12/04/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said Wednesday a phase 3 study of its fremanezumab drug to prevent episodic migraine in patients aged 6 to 17 years showed statistically significant superior efficacy compared with placebo. The drug also showed a favorable safety profile consistent with that observed in the adult population, the company...

04:29 AM EST, 12/04/2024 (MT Newswires) -- Coterra Energy ( CTRA ) said late Tuesday that it priced $750 million senior unsecured notes due 2035 at a 5.40% interest rate and $750 million senior unsecured notes due 2055 at a 5.90% interest rate. Proceeds from the offerings, expected to close on Dec. 17, along with cash and borrowings, would fund...

04:20 AM EST, 12/04/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) said late Tuesday it has priced an offering of 14.1 million shares at $46 per share and pre-funded warrants to purchase 2.2 million shares at $45.9999. The company also said it has granted underwriters a 30-day option to purchase up to 2.4 million additional shares. The gross proceeds...

04:13 AM EST, 12/04/2024 (MT Newswires) -- Intuitive Machines ( LUNR ) said late Tuesday it priced an upsized offering of about 9.5 million shares of its class A common stock at $10.50 per share. The company and a selling stockholder granted the underwriters a 30-day option to buy up to an additional about 1.3 million and 152,857 shares, respectively....